United States· US:49967-512_61f5c62e-a06b-4e06-868a-db8df7fcb16b
CeraVe Developed with Dermatologists Itch Relief Moisturizing
A medicinal product containing pramoxine hydrochloride, registered in United States by L'Oreal USA Products Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PRAMOXINE HYDROCHLORIDE
- Manufacturer
- L'Oreal USA Products Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc114996751201340 g in 1 JAR (49967-512-01)
- ndc114996751202453.6 g in 1 JAR (49967-512-02)
- ndc114996751203538.6 g in 1 JAR (49967-512-03)
- ndc1149967-512-01
- ndc1149967-512-02
- ndc1149967-512-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pramoxine hydrochloride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceCEMAUKOR 1%, gel pour application localeBOUCHARA-RECORDATI
- CanadaITCH RELIEF MOISTURIZING CREAMCERAVE CANADA
- United KingdomAnugesic-HC suppositoriesPfizer Ltd
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Cemaukor, Pramocaine Chlorhydrate Arrow Conseil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8687637-1663-4a6d-ab37-2113077cf4e0 GET /v1/drugs/f8687637-1663-4a6d-ab37-2113077cf4e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10",
"substance": "PRAMOXINE HYDROCHLORIDE",
"productndc": "49967-512",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about pramoxine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.